Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis

Clinical Trial ID NCT01722214

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01722214

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005 28.21
2 Risk of myocardial infarction in patients with psoriasis. JAMA 2006 9.42
3 Severe psoriasis--oral therapy with a new retinoid. Dermatologica 1978 5.67
4 Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 2007 3.34
5 The risk of stroke in patients with psoriasis. J Invest Dermatol 2009 2.97
6 Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 2010 2.46
7 Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol 2005 2.17
8 Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol 2009 2.01
9 Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study. Arch Dermatol 2011 1.88
10 Assessment of disease progress in psoriasis. Arch Dermatol 1989 1.59
11 Systemic inflammation as a risk factor for atherothrombosis. Rheumatology (Oxford) 2007 1.43
12 Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis 2006 1.42
13 Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort. Eur Heart J 2007 1.10
14 What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology. Ann Rheum Dis 2007 1.09
15 Prognosis following first-time myocardial infarction in patients with psoriasis: a Danish nationwide cohort study. J Intern Med 2011 0.94
16 Anti-inflammatory drugs and atherosclerosis. Curr Opin Lipidol 2007 0.86
Next 100